167 related articles for article (PubMed ID: 21912228)
1. A new target for Staphylococcus aureus associated with keratitis.
Suzuki T
Cornea; 2011 Oct; 30 Suppl 1():S34-40. PubMed ID: 21912228
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates.
Suzuki T; Swoboda JG; Campbell J; Walker S; Gilmore MS
Antimicrob Agents Chemother; 2011 Feb; 55(2):767-74. PubMed ID: 21098254
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
[TBL] [Abstract][Full Text] [Related]
4. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterisation of methicillin-resistant Staphylococcus aureus (MRSA) from keratitis patients: a microbiological analysis.
Khan MA; Ahmad S; Banu N
Br J Ophthalmol; 2010 Aug; 94(8):994-8. PubMed ID: 20472743
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus.
Freidlin J; Acharya N; Lietman TM; Cevallos V; Whitcher JP; Margolis TP
Am J Ophthalmol; 2007 Aug; 144(2):313-5. PubMed ID: 17659970
[TBL] [Abstract][Full Text] [Related]
7. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
Sharma V; Sharma S; Garg P; Rao GN
Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
[TBL] [Abstract][Full Text] [Related]
8. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
Hawser SP; Bouchillon SK; Hoban DJ; Dowzicky M; Babinchak T
Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146
[TBL] [Abstract][Full Text] [Related]
9. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005.
Asbell PA; Sahm DF; Shaw M; Draghi DC; Brown NP
J Cataract Refract Surg; 2008 May; 34(5):814-8. PubMed ID: 18471638
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
Udo EE; Al-Sweih N; Dhar R; Dimitrov TS; Mokaddas EM; Johny M; Al-Obaid IA; Gomaa HH; Mobasher LA; Rotimi VO; Al-Asar A
Med Princ Pract; 2008; 17(1):71-5. PubMed ID: 18059105
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco].
Elhamzaoui S; Benouda A; Allali F; Abouqual R; Elouennass M
Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758
[TBL] [Abstract][Full Text] [Related]
13. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Callegan MC; Engel LS; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
[TBL] [Abstract][Full Text] [Related]
15. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus.
Marino A; Blanco AR; Ginestra G; Nostro A; Bisignano G
Int J Antimicrob Agents; 2016 Oct; 48(4):395-400. PubMed ID: 27554440
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes.
Major JC; Engelbert M; Flynn HW; Miller D; Smiddy WE; Davis JL
Am J Ophthalmol; 2010 Feb; 149(2):278-283.e1. PubMed ID: 19926069
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
Appleman MD; Citron DM
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
[TBL] [Abstract][Full Text] [Related]
19. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
Dalhoff A; Schubert S
Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]